S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The gold catalyst we’ve waited for (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
The gold catalyst we’ve waited for (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The gold catalyst we’ve waited for (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
The gold catalyst we’ve waited for (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The gold catalyst we’ve waited for (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
The gold catalyst we’ve waited for (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The gold catalyst we’ve waited for (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
The gold catalyst we’ve waited for (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
NASDAQ:CSX

CSX - CSX Earnings Date, Estimates & Call Transcripts

$28.75
+0.50 (+1.77%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$28.28
$28.88
50-Day Range
$28.08
$32.64
52-Week Range
$25.80
$38.17
Volume
11.46 million shs
Average Volume
14.07 million shs
Market Capitalization
$59.30 billion
P/E Ratio
14.82
Dividend Yield
1.53%
Price Target
$34.39

Earnings Summary

Upcoming
Earnings Date
Apr. 20Confirmed
Actual EPS
(Jan. 25)
$0.49 Beat By $0.02
Consensus EPS
(Jan. 25)
$0.47
Last Year's Q1 EPS
(1/20/2022)
$0.42
Skip Charts & View Estimated and Actual Earnings Data

CSX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CSX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CSX Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231$0.44$0.44$0.44 
Q2 20231$0.49$0.49$0.49 
Q3 20231$0.50$0.50$0.50 
Q4 20231$0.34$0.34$0.34 
FY 20234$1.77$1.77$1.77 
Q1 20241$0.47$0.47$0.47 
Q2 20241$0.42$0.42$0.42 
Q3 20241$0.50$0.50$0.50 

CSX Earnings Date and Information

CSX last announced its earnings data on January 25th, 2023. The transportation company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.02. The business earned $3.73 billion during the quarter, compared to analyst estimates of $3.72 billion. Its quarterly revenue was up 8.7% compared to the same quarter last year. CSX has generated $1.94 earnings per share over the last year ($1.94 diluted earnings per share) and currently has a price-to-earnings ratio of 14.8. Earnings for CSX are expected to grow by 7.53% in the coming year, from $1.86 to $2.00 per share. CSX has confirmed that its next quarterly earnings report will be published on Thursday, April 20th, 2023. CSX will be holding an earnings conference call on Thursday, April 20th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

CSX Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/20/2023
(Confirmed)
 $0.43       
1/25/2023Q4 22$0.47$0.49+$0.02$0.49$3.72 billion$3.73 billion    
10/20/2022Q3 2022$0.49$0.52+$0.03$0.52$3.75 billion$3.90 billion    
7/20/2022Q2 2022$0.47$0.50+$0.03$0.46$3.67 billion$3.82 billion    
4/20/2022Q1 2022$0.38$0.39+$0.01$0.39$3.31 billion$3.41 billion    
1/20/2022Q4 2021$0.41$0.42+$0.01$0.42$3.32 billion$3.43 billion    
10/19/20219/30/2021$0.38$0.43+$0.05$0.43$3.06 billion$3.29 billion    
7/20/20216/30/2021$0.37$0.39+$0.02$0.28$2.94 billion$2.99 billion    
4/19/20213/31/2021$0.3167$0.31($0.0067)$0.93$2.80 billion$2.81 billion  
1/20/202112/31/2020$0.3333$0.3467+$0.0133$1.09$2.75 billion$2.83 billion  
10/21/20209/30/2020$0.31$0.32+$0.01$0.96$2.68 billion$2.65 billion  
7/22/20206/30/2020$0.2133$0.2167+$0.0033$0.65$2.31 billion$2.26 billion  
4/22/20203/31/2020$0.3133$0.3333+$0.02$1.00$2.88 billion$2.86 billion  
1/16/2020Q4 2019$0.3233$0.33+$0.0067$0.99$2.94 billion$2.89 billion  
10/16/2019Q3 2019$0.34$0.36+$0.02$1.08$2.98 billion$2.98 billion  
7/16/2019Q2 19$0.37$0.36($0.01)$1.08$3.14 billion$3.06 billion  
4/16/20193/31/2019$0.3033$0.34+$0.0367$1.02$3.00 billion$3.01 billion  
1/16/2019Q4 2018$0.3367$0.3367$1.01$3.12 billion$3.14 billion  
10/16/20189/30/2018$0.3133$0.35+$0.0367$1.05$3.05 billion$3.13 billion  
7/17/2018Q2 2018$0.2867$0.3367+$0.05$1.01$3.00 billion$3.10 billion
4/17/2018Q1 2018$0.22$0.26+$0.04$0.78$2.80 billion$2.88 billion  
1/16/2018Q4 2017$0.1867$0.2133+$0.0267($3.34)$2.89 billion$2.86 billion  
10/17/2017Q3 2017$0.17$0.17$0.51$2.77 billion$2.74 billion
7/18/2017Q2 2017$0.1967$0.2127+$0.0160$0.73$2.85 billion$2.93 billion
4/19/2017Q1 2017$0.1433$0.17+$0.0267$0.63$2.76 billion$2.87 billion
1/17/2017Q416$0.1633$0.1633$0.49$2.86 billion$3.04 billion  
10/12/2016Q316$0.15$0.16+$0.01$0.48$2.69 billion$2.71 billion  
7/13/2016Q216$0.1467$0.1567+$0.01$0.47$2.69 billion$2.70 billion  
4/12/2016Q1$0.1233$0.1233$0.37$2.73 billion$2.62 billion  
1/12/2016$0.1533$0.16+$0.0067  
1/12/2016Q415$0.1533$0.16+$0.0067$2.78 billion  
1/12/2016Q4 2015$0.1533$0.16+$0.0067$0.48$2.90 billion$2.78 billion  
10/13/2015Q315$0.1667$0.1733+$0.0067$0.52$3.01 billion$2.94 billion  
7/14/2015Q215$0.1767$0.1867+$0.01$0.56$3.12 billion$3.06 million  
4/14/2015Q115$0.1467$0.15+$0.0033$0.45$3.05 billion$3.00 billion  
1/13/2015Q414$0.1633$0.1633$0.49$3.18 billion$3.20 billion  
10/14/2014Q314$0.1567$0.17+$0.0133$0.51$3.14 billion$3.20 billion  
7/15/2014Q214$0.1733$0.1767+$0.0033$0.53$3.23 billion$3.24 billion  
4/15/2014Q114$0.1267$0.1333+$0.0067$0.40$2.98 billion$3.01 billion  
2/12/2014Q4 2013$0.1433$0.14($0.0033)$0.42$3.01 billion$3.03 billion
1/16/2014Q413$0.14$0.14$2.98 billion$3.00 billion  
10/15/2013Q3 2013$0.14$0.1533+$0.0133$0.46$2.94 billion$3.00 billion  
7/16/2013Q2 2013$0.1567$0.1733+$0.0167$0.52$3.00 billion$3.07 billion  
4/16/2013Q1 2013$0.1333$0.15+$0.0167$0.45$2.92 billion$2.96 billion  
1/22/2013Q4 2012$0.13$0.1433+$0.0133$2.85 billion$2.90 billion  
10/16/2012$0.1433$0.1467+$0.0033
7/17/2012$0.1567$0.1633+$0.0067
4/17/2012$0.1267$0.1433+$0.0167
1/23/2012$0.1467$0.1433($0.0033)
10/18/2011$0.1433$0.1433
7/19/2011$0.1467$0.1533+$0.0067
4/19/2011$0.3467$0.3533+$0.0067
1/24/2011$0.3667$0.38+$0.0133  
10/12/2010Q3 2010$0.1167$0.12+$0.0033$0.36
7/12/2010Q2 2010$0.1067$0.12+$0.0133$0.36
4/13/2010Q1 2010$0.0767$0.0867+$0.01$0.26
1/19/2010Q4 2009$0.0833$0.0867+$0.0033$0.26
10/13/2009Q3 2009$0.08$0.0833+$0.0033$0.25
7/13/2009Q2 2009$0.07$0.08+$0.01$0.22
4/14/2009Q1 2009$0.06$0.07+$0.01$0.21
1/20/2009Q4 2008$0.10$0.10$0.39
7/15/2008Q2 2008$0.10$0.10$0.29
4/15/2008Q1 2008$0.08$0.09+$0.01$0.26
1/22/2008Q4 2007$0.07$0.0933+$0.0233$0.27












CSX Earnings - Frequently Asked Questions

When is CSX's earnings date?

CSX has confirmed that its next quarterly earnings data will be published on Thursday, April 20th, 2023. Learn more on CSX's earnings history.

Did CSX beat their earnings estimates last quarter?

In the previous quarter, CSX (NASDAQ:CSX) reported $0.49 earnings per share (EPS) to beat the analysts' consensus estimate of $0.47 by $0.02. Learn more on analysts' earnings estimate vs. CSX's actual earnings.

How can I listen to CSX's earnings conference call?

The conference call for CSX's latest earnings report can be listened to online. Listen to Conference Call

How can I read CSX's conference call transcript?

The conference call transcript for CSX's latest earnings report can be read online. Read Transcript

How much revenue does CSX generate each year?

CSX (NASDAQ:CSX) has a recorded annual revenue of $14.85 billion.

How much profit does CSX generate each year?

CSX (NASDAQ:CSX) has a recorded net income of $4.17 billion. CSX has generated $1.94 earnings per share over the last four quarters.

What is CSX's price-to-earnings ratio?

CSX (NASDAQ:CSX) has a trailing price-to-earnings ratio of 14.82 and a forward price-to-earnings ratio of 15.46. The price/earnings-to-growth ratio is 2.19.

What is CSX's EPS forecast for next year?

CSX's earnings are expected to grow from $1.86 per share to $2.00 per share in the next year, which is a 7.53% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:CSX) was last updated on 3/28/2023 by MarketBeat.com Staff